Medicover AB (MCOVb)

Currency in SEK
267.0000
+2.5000(+0.95%)
Closed·
MCOVb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
258.0000267.0000
52 wk Range
179.4000284.5000
Key Statistics
Prev. Close
267
Open
262
Day's Range
258-267
52 wk Range
179.4-284.5
Volume
153.37K
Average Volume (3m)
76.77K
1-Year Change
13.8593%
Book Value / Share
40.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MCOVb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
281.2390
Upside
+5.33%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Medicover AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 281.2390
(+5.33% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold238.00-10.86%220.00MaintainAug 10, 2026

Medicover AB Earnings Call Summary for Q3/2026

  • Medicover Q3 EPS of EUR 0.16 missed forecast of $0.1732 by 7.6%; shares fell 2.9% to $268 despite 8% organic revenue growth and 22% EBIT increase.
  • Company achieved seventh consecutive quarter of margin improvement with EBIT margin up 110 bps and adjusted EBITDA margin rising to 17.8% from 17.6%.
  • India business sale expected to generate EUR 740M for 66.1% stake, closing November 2026, leaving Medicover near debt-free with leverage at 2.7x.
  • Near-term headwinds include German genetics reimbursement changes, 4% Romania membership decline, and facility restructuring affecting 118 closures vs 140 openings.
  • Management maintains full-year CapEx guidance at 6-6.5% of revenue; prioritizes India deal closure before capital allocation decisions on M&A and expansion.
Last Updated: 04/11/2026, 10:34
Read Full Transcript

Earnings

Latest Release
Nov 04, 2026
EPS / Forecast
0.16 / 0.17
Revenue / Forecast
570.8M / 639.13M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.71
Dividend Yield
0.82%
Industry Median 1.12%
Annualised payout
2.17
Paid annually
5-Years Growth
+23.36%
Growth Streak

MCOVb Income Statement

Compare MCOVb to Peers and Sector

Metrics to compare
MCOVb
Peers
Sector
Relationship
P/E Ratio
41.1x18.6x−0.2x
PEG Ratio
0.991.020.00
Price/Book
6.8x2.7x2.6x
Price / LTM Sales
1.5x0.8x2.8x
Upside (Analyst Target)
5.3%19.4%65.6%
Fair Value Upside
Unlock7.8%10.0%Unlock

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Employees
49000
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
18.18M11.96%4.85B
Other Institutional Investors
98.94M65.10%26.42B
Public Companies & Retail Investors
34.85M22.93%9.31B
Total
151.97M100.00%40.58B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Celox Holding AB31.03%47,157,36512,591,016
Estate Of Jonas Af Jochnick13.02%19,779,9355,281,243

People Also Watch

129.65
LEGD
+1.65%
503.40
BOL
-0.83%
532.0
ALFA
-1.37%
94.0
HPOLb
-1.36%
128.9500
MTRS
+0.19%

FAQ

What Is the Medicover (MCOVb) Stock Price Today?

The Medicover stock price today is 267.0000 SEK.

What Stock Exchange Does Medicover Trade On?

Medicover is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Medicover?

The stock symbol for Medicover is "MCOVb."

What Is the Medicover Market Cap?

As of today, Medicover market cap is 40.5800B SEK.

What Is Medicover's Earnings Per Share (TTM)?

The Medicover EPS (TTM) is 6.71.

When Is the Next Medicover Earnings Date?

Medicover will release its next earnings report on Feb 10, 2027.

From a Technical Analysis Perspective, Is MCOVb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Medicover Stock Split?

Medicover has split 0 times.

How Many Employees Does Medicover Have?

Medicover has 49000 employees.

What is the current trading status of Medicover (MCOVb)?

As of Nov 07, 2026, Medicover (MCOVb) is trading at a price of 267.0000 SEK, with a previous close of 267.0000 SEK. The stock has fluctuated within a day range of 258.0000 SEK to 267.0000 SEK, while its 52-week range spans from 179.4000 SEK to 284.5000 SEK.

What Is Medicover (MCOVb) Price Target According to Analysts?

The average 12-month price target for Medicover is 281.2390 SEK, with a high estimate of 351.94046307 SEK and a low estimate of 237.40904079 SEK. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +5.33% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.